Keyphrases
Aspirin
100%
Asymmetric Dimethylarginine
71%
Beneficial Effects
14%
Cardiology
14%
Clinically Significant
42%
Competitive Inhibitor
14%
Confidence Interval
28%
Daily Dose
28%
Disease Event
14%
Dose Increase
14%
Downstream Targets
14%
Heme Oxygenase (HO)-1
14%
Heme oxygenase-1 (HO-1)
57%
Nitric Oxide Production
100%
Nitric Oxide Synthase Inhibitors
14%
No Significant Difference
14%
Non-invasive Method
14%
Office Practice
14%
Peripheral Vascular Disease
14%
Random Data
28%
Randomized Comparison
14%
Randomized Double-blind Trial
14%
Ratio of Means
28%
Secondary Prevention
28%
Stable Coronary Artery Disease
100%
Pharmacology, Toxicology and Pharmaceutical Science
6 N,n' Dimethylarginine
71%
Acetylsalicylic Acid
100%
Atherosclerosis
14%
Competitive Inhibitor
14%
Coronary Artery Disease
100%
Heme Oxygenase
14%
N(g),n(g) Dimethylarginine
71%
Nitric Oxide
100%
Nitric Oxide Synthase
14%
Peripheral Occlusive Artery Disease
14%
Neuroscience
6 N,n' Dimethylarginine
71%
Aspirin
100%
Competitive Inhibition
14%
Heme Oxygenase
14%
Nitric Oxide
100%
Nitric Oxide Synthase
14%
Vascular Disease
14%